Evidence map›Paper›PMID 36453584›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Tumor Cell-Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis.

Ningning Niu, Xuqing Shen, Li Zhang, Yueyue Chen, Ping Lu, Wenjuan Yang, Mingzhu Liu, Juanjuan Shi, Dapeng Xu, Yingying Tang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Loss of SETD2-mediated H3K36me3 Drives CD8Research (Washington, D.C.) · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Ningning NiuState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Xuqing ShenState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Li ZhangState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Yueyue ChenState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Ping LuState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Wenjuan YangState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Mingzhu LiuState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Juanjuan ShiState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Dapeng XuDepartment of Biliary-Pancreatic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Yingying TangState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Xiaotong YangState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Yawen WengState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Xinxin ZhaoDepartment of Radiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Lian-Ming WuDepartment of Radiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Yongwei SunDepartment of Biliary-Pancreatic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.
Jing XueState Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai, 200127, P. R. China.ORCID 0000-0002-6497-1792
Shanghai Jiao Tong University · CN

Funding

Innovative Research Team of High-Level Local Universities in ShanghaiNational Natural Science Foundation of China 81770628National Natural Science Foundation of China 81802307National Natural Science Foundation of China 81970553National Natural Science Foundation of China 82022049National Natural Science Foundation of China 82073105Science and Technology Commission of Shanghai Municipality 20ZR1432900Shanghai Municipal Education Commission-Gaofeng Clinical Medicine 20161312Shanghai Rising-Star Program 19QA1408300State Key Laboratory of Oncogenes and Related Genes KF2113
6 · The paper itself

Abstract

Genetic and epigenetic alterations play central roles in shaping the immunosuppressive tumor microenvironment (TME) to evade immune surveillance. The previous study shows that SETD2-H3K36me3 loss promotes KRAS-induced pancreatic tumorigenesis. However, little is known about its role in remodeling the TME and immune evasion. Here, it is shown that SETD2 deficiency can reprogram neutrophils to an immunosuppressive phenotype, thereby promoting immune escape during pancreatic tumor progression. By comprehensive profiling of the intratumoral immune cells, neutrophils are identified as the subset with the most significant changes upon Setd2 loss. Setd2-deficient pancreatic tumor cells directly enhance neutrophil recruitment and reprogramming, thereby inhibiting the cytotoxicity of CD8

Indexed as

NeutrophilsPancreatic NeoplasmsCarcinogenesisCD8-Positive T-LymphocytesCell Transformation, NeoplasticHistone-Lysine N-MethyltransferaseHumansPhosphatidylinositol 3-KinasesTumor MicroenvironmentHistone-Lysine N-MethyltransferasePhosphatidylinositol 3-KinasesSETD2 protein, humanimmune evasionneutrophilpancreatic tumorigenesisSETD2

Identifiers

PMID36453584
PMCPMC9839845
OpenAlexW4310565211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.